A Derbyshire driver who self-medicated a neurological disorder with Ketamine caused a “devastating” multiple-car pileup – ...

The Department of Defense is funding research being carried out by the Larner College of Medicine and UVM Medical Center into ...

The US Food and Drug Administration (FDA) approved the first-ever anti-depression nasal spray, Spravato. The pharmaceutical ...

Ketamine is a short-acting anesthetic that has been used for decades in medical settings. In recent years, researchers have ...

A nasal spray that contains esketamine — a potent derivative of ketamine — can now be taken on its own to treat adults with ...

A new study has found small amounts of liquid ketamine administered in a clinical setting can significantly reduce symptoms ...

Ketamine-assisted psychotherapy (KAP) uses low doses of ketamine alongside psychotherapy to treat mental health conditions.

People with treatment-resistant depression can now take Spravato's ketamine-derived nasal spray as a standalone treatment.

The dosage for bupropion varies depending on the condition it’s being used to treat and the form of the drug you’re prescribed. Your doctor will prescribe the dosage and form that’s best for ...

This article will discuss the recommended hepatitis vaccine schedule for children and adults, including doses, timing, side effects, and who should get the vaccine. The following vaccines are approved ...

Spravato is now the first stand-alone therapy for treatment-resistant depression, for patients who haven't responded to oral ...

The ketamine-derived drug was first approved in 2019 to be used in combination with antidepressants, and later for patients experiencing suicidal thoughts or actions. “Now that it is also ...